GreenLight Biosciences Holdings, (GRNA) Social Stream
GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GRNA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-08 | 1 | $4 | $4 | $4 | $0.414 | 866.18% |
Price Target Last Issued December 8, 2022
GRNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, GREENLIGHT BIOSCIENCES HOLDINGS PBC's number of analysts covering the stock is higher than just about none of of them.
- In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to all US stocks, note that its variance in analysts' estimates is lower than almost 100% of that group.
- In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to Healthcare stocks, note that its average analyst price target is higher than 4.68% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, GREENLIGHT BIOSCIENCES HOLDINGS PBC's upside potential (average analyst target price relative to current price) is higher than 87.3% of them.
Stocks similar to GREENLIGHT BIOSCIENCES HOLDINGS PBC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VOR, FNCH, and IKNA.
View All Top Stocks by Price Target
What is the outlook for GRNA? Use POWR Ratings for clearer insight into price direction.